Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rentokil
RTO
|
+$514M |
| 2 |
APLS
Apellis Pharmaceuticals
APLS
|
+$210M |
| 3 |
TFI International
TFII
|
+$145M |
| 4 |
Ambev
ABEV
|
+$142M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$133M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$8.38B |
| 2 |
Apple
AAPL
|
+$5.7B |
| 3 |
Amazon
AMZN
|
+$3.72B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.64B |
| 5 |
Mastercard
MA
|
+$3.47B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.11% |
| 2 | Healthcare | 21.42% |
| 3 | Financials | 11.42% |
| 4 | Industrials | 10.73% |
| 5 | Consumer Discretionary | 10.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Acuity Brands
AYI
$9.99B
| $35.6M | 0.03% |
214,895
-283,785
| -57% | -$50.4M |
|
452
Graphic Packaging
GPK
$3.35B
| $35.5M | 0.03% |
1,595,501
-2,017,573
| -56% | -$44.4M |
|
453
Martin Marietta Materials
MLM
$34.2B
| $34.8M | 0.02% |
102,855
-60,947
| -37% | -$20.8M |
|
454
Booz Allen Hamilton
BAH
$8.44B
| $34.7M | 0.02% |
331,853
-228,041
| -41% | -$23.7M |
|
455
Collegium Pharmaceutical
COLL
$1.18B
| $34.4M | 0.02% |
1,481,170
-2,350,826
| -61% | -$47.4M |
|
|
DICE
456
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $34.1M | 0.02% |
1,093,418
-2,177,878
| -67% | -$71M |
|
457
Sanofi
SNY
$107B
| $33.9M | 0.02% |
700,315
-481,021
| -41% | -$21.1M |
|
|
CLVT.PRA
458
DELISTED
Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares
CLVT.PRA
| $33.6M | 0.02% |
881,277
-626,277
| -42% | -$26.3M |
|
459
Criteo S.A. Ordinary Shares
CRTO
$1.14B
| $33.4M | 0.02% |
1,280,745
-1,169,587
| -48% | -$30.3M |
|
460
Champion Homes
SKY
$4.41B
| $33.4M | 0.02% |
647,884
-949,544
| -59% | -$50.5M |
|
461
Lamb Weston
LW
$7.42B
| $33.4M | 0.02% |
373,356
-625,122
| -63% | -$53.2M |
|
462
Canadian Pacific Kansas City
CP
$81B
| $32.9M | 0.02% |
440,969
-589,553
| -57% | -$44.4M |
|
463
Waste Management
WM
$95B
| $32.8M | 0.02% |
208,955
-228,761
| -52% | -$36.8M |
|
464
RenaissanceRe
RNR
$13.8B
| $32.7M | 0.02% |
177,549
-436,451
| -71% | -$73.5M |
|
465
Regions Financial
RF
$26.4B
| $32.7M | 0.02% |
1,514,726
-1,891,838
| -56% | -$41M |
|
466
4D Molecular Therapeutics
FDMT
$502M
| $32.6M | 0.02% |
1,466,267
-1,173,195
| -44% | -$18.1M |
|
467
Invesco NASDAQ 100 ETF
QQQM
$93B
| $32.1M | 0.02% |
+293,073
| New | +$33.3M |
|
468
Bath & Body Works
BBWI
$3.97B
| $31.8M | 0.02% |
754,001
-527,503
| -41% | -$19.7M |
|
|
MYOV
469
DELISTED
Myovant Sciences Ltd.
MYOV
| $31.7M | 0.02% |
1,177,158
-6,730,524
| -85% | -$177M |
|
470
SK Telecom
SKM
$11.4B
| $31.5M | 0.02% |
1,528,187
-1,528,187
| -50% | -$31M |
|
471
Wolfspeed
WOLF
$1.04B
| $31.5M | 0.02% |
455,616
-480,694
| -51% | -$42.6M |
|
472
Phillips Edison & Co
PECO
$5.5B
| $31.2M | 0.02% |
979,810
-1,325,180
| -57% | -$40.7M |
|
473
Sportradar
SRAD
$4.42B
| $31.1M | 0.02% |
3,123,523
-3,125,229
| -50% | -$30.5M |
|
474
FB Financial Corp
FBK
$2.98B
| $31M | 0.02% |
858,186
-582,824
| -40% | -$23.3M |
|
475
Shift4
FOUR
$4.45B
| $31M | 0.02% |
554,221
-359,555
| -39% | -$17M |
|
Similar funds
Janus Henderson Group's Q4 2022 Portfolio in Review
As of Q4 2022, Janus Henderson Group held 2,666 positions worth $140B, down 48% from $267B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Janus Henderson Group withdrew a net $148B in Q4 2022, closing 210 positions and reducing 1,907 holdings. Its most notable exit was Terminix Global Holdings, Inc., an estimated $901M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Janus Henderson Group opened a new position in Rentokil worth $510M.
- Janus Henderson Group's largest Q4 2022 buy was Rentokil: 16,564,405 shares worth $510M.
- Janus Henderson Group added most to Apellis Pharmaceuticals in Q4 2022, an estimated $210M increase.
- Janus Henderson Group's biggest Q4 2022 reduction was Microsoft, cutting an estimated $8.38B.
- Janus Henderson Group fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $901M.
- Janus Henderson Group's ten largest holdings make up 22% of its $140B portfolio in Q4 2022.
- Janus Henderson Group opened 131 new positions and closed 210 in Q4 2022.
- Janus Henderson Group's portfolio value fell 48% quarter-over-quarter to $140B.
Based on Janus Henderson Group's 13F filing for Q4 2022, filed 14 Feb 2023.